siRNA treatment decreases triglycerides in clients with unusual ailment

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and lowered the threat of pancreatitis in clients along with constant chylomicronemia, along with or without a hereditary diagnosis.